Vanguard Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.93B Buy
1,672,255
+115,621
+7% +$136M 1.2% 14
2026
Q2
$1.87B Buy
1,556,634
+166,734
+12% +$170M 1.26% 12
2026
Q1
$1.28B Buy
+1,389,900
New +$1.41B 1.09% 13

Other funds holding LLY

Vanguard Asset Management's LLY Position: Q3 2026 in Review

Vanguard Asset Management increased its Eli Lilly (LLY) stake by 7.4% in Q3 2026, buying an estimated $136M and bringing the position to 1,672,255 shares worth $1.93B. The position accounts for 1.2% of the portfolio, ranked #14.

Vanguard Asset Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vanguard Asset Management held 1,672,255 shares of Eli Lilly worth $1.93B as of Q3 2026.
  • Vanguard Asset Management bought 115,621 Eli Lilly shares in Q3 2026, an estimated $136M.
  • Eli Lilly made up 1.2% of Vanguard Asset Management's portfolio in Q3 2026, its #14 holding.
  • Vanguard Asset Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.